Molecular imaging as biomarker for treatment response and outcome in breast cancer

Molecular imaging, such as positron emission tomography (PET), is increasingly used as biomarker to predict and assess treatment response in breast cancer. The number of biomarkers is expanding with specific tracers for tumour characteristics throughout the body and this information can be used to a...

Descripción completa

Detalles Bibliográficos
Autores principales: van Geel, Jasper J. L., de Vries, Erik F. J., van Kruchten, Michel, Hospers, Geke A. P., Glaudemans, Andor W. J. M., Schröder, Carolina P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201167/
https://www.ncbi.nlm.nih.gov/pubmed/37223262
http://dx.doi.org/10.1177/17588359231170738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201167/
https://www.ncbi.nlm.nih.gov/pubmed/37223262
http://dx.doi.org/10.1177/17588359231170738

Ejemplares similares